vs

Side-by-side financial comparison of Beta Bionics, Inc. (BBNX) and LIGHTPATH TECHNOLOGIES INC (LPTH). Click either name above to swap in a different company.

Beta Bionics, Inc. is the larger business by last-quarter revenue ($27.6M vs $16.4M, roughly 1.7× LIGHTPATH TECHNOLOGIES INC). LIGHTPATH TECHNOLOGIES INC runs the higher net margin — -57.5% vs -79.3%, a 21.7% gap on every dollar of revenue. On growth, LIGHTPATH TECHNOLOGIES INC posted the faster year-over-year revenue change (120.2% vs 56.6%).

Beta Bionics, Inc. is a medical technology company focused on developing and commercializing advanced automated diabetes management solutions. Its core product is the iLet Bionic Pancreas, a wearable device that automatically adjusts insulin and glucagon delivery for people with Type 1 and Type 2 diabetes, serving primarily the U.S. healthcare market with plans for global expansion.

LightPath Technologies Inc designs, manufactures and distributes high-precision optical components and assemblies, including aspheric lenses, infrared optics, and fiber optic products. It serves global clients across industrial automation, aerospace, defense, medical imaging, and telecommunications sectors.

BBNX vs LPTH — Head-to-Head

Bigger by revenue
BBNX
BBNX
1.7× larger
BBNX
$27.6M
$16.4M
LPTH
Growing faster (revenue YoY)
LPTH
LPTH
+63.6% gap
LPTH
120.2%
56.6%
BBNX
Higher net margin
LPTH
LPTH
21.7% more per $
LPTH
-57.5%
-79.3%
BBNX

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
BBNX
BBNX
LPTH
LPTH
Revenue
$27.6M
$16.4M
Net Profit
$-21.9M
$-9.4M
Gross Margin
59.5%
36.8%
Operating Margin
-47.4%
-52.6%
Net Margin
-79.3%
-57.5%
Revenue YoY
56.6%
120.2%
Net Profit YoY
23.6%
-260.1%
EPS (diluted)
$-0.49
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BBNX
BBNX
LPTH
LPTH
Q1 26
$27.6M
Q4 25
$32.1M
$16.4M
Q3 25
$27.3M
$15.1M
Q2 25
$23.2M
$12.2M
Q1 25
$17.6M
$9.2M
Q4 24
$7.4M
Q3 24
$8.4M
Q2 24
$8.6M
Net Profit
BBNX
BBNX
LPTH
LPTH
Q1 26
$-21.9M
Q4 25
$-13.5M
$-9.4M
Q3 25
$-14.2M
$-2.9M
Q2 25
$-16.9M
$-7.1M
Q1 25
$-28.7M
$-3.6M
Q4 24
$-2.6M
Q3 24
$-1.6M
Q2 24
$-2.4M
Gross Margin
BBNX
BBNX
LPTH
LPTH
Q1 26
59.5%
Q4 25
59.0%
36.8%
Q3 25
55.5%
29.8%
Q2 25
53.8%
22.0%
Q1 25
50.9%
29.1%
Q4 24
26.0%
Q3 24
33.9%
Q2 24
29.2%
Operating Margin
BBNX
BBNX
LPTH
LPTH
Q1 26
-47.4%
Q4 25
-50.2%
-52.6%
Q3 25
-62.5%
-16.6%
Q2 25
-85.5%
-38.0%
Q1 25
-105.7%
-36.3%
Q4 24
-33.5%
Q3 24
-16.4%
Q2 24
-25.6%
Net Margin
BBNX
BBNX
LPTH
LPTH
Q1 26
-79.3%
Q4 25
-41.9%
-57.5%
Q3 25
-52.1%
-19.2%
Q2 25
-72.6%
-57.8%
Q1 25
-162.5%
-39.1%
Q4 24
-35.2%
Q3 24
-19.3%
Q2 24
-27.3%
EPS (diluted)
BBNX
BBNX
LPTH
LPTH
Q1 26
$-0.49
Q4 25
$-0.16
$-0.20
Q3 25
$-0.33
$-0.07
Q2 25
$-0.39
$0.19
Q1 25
$-0.93
$-0.44
Q4 24
$-0.07
Q3 24
$-0.04
Q2 24
$-0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BBNX
BBNX
LPTH
LPTH
Cash + ST InvestmentsLiquidity on hand
$199.5M
$73.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$271.2M
$77.9M
Total Assets
$304.4M
$148.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BBNX
BBNX
LPTH
LPTH
Q1 26
$199.5M
Q4 25
$219.1M
$73.6M
Q3 25
$228.7M
Q2 25
$249.7M
$4.9M
Q1 25
$231.5M
Q4 24
Q3 24
Q2 24
Total Debt
BBNX
BBNX
LPTH
LPTH
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$535.0K
Stockholders' Equity
BBNX
BBNX
LPTH
LPTH
Q1 26
$271.2M
Q4 25
$287.6M
$77.9M
Q3 25
$294.8M
$21.4M
Q2 25
$301.6M
$15.6M
Q1 25
$313.8M
$15.7M
Q4 24
$26.7M
Q3 24
$29.4M
Q2 24
$30.2M
Total Assets
BBNX
BBNX
LPTH
LPTH
Q1 26
$304.4M
Q4 25
$328.7M
$148.6M
Q3 25
$330.0M
$87.3M
Q2 25
$330.0M
$81.5M
Q1 25
$338.0M
$81.4M
Q4 24
$45.8M
Q3 24
$48.4M
Q2 24
$48.1M
Debt / Equity
BBNX
BBNX
LPTH
LPTH
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BBNX
BBNX
LPTH
LPTH
Operating Cash FlowLast quarter
$2.8M
Free Cash FlowOCF − Capex
$2.0M
FCF MarginFCF / Revenue
12.0%
Capex IntensityCapex / Revenue
5.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-6.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BBNX
BBNX
LPTH
LPTH
Q1 26
Q4 25
$-8.6M
$2.8M
Q3 25
$-8.7M
$-1.1M
Q2 25
$-13.6M
$-2.6M
Q1 25
$-20.0M
$-3.2M
Q4 24
$-737.4K
Q3 24
$-1.7M
Q2 24
$64.7K
Free Cash Flow
BBNX
BBNX
LPTH
LPTH
Q1 26
Q4 25
$-10.5M
$2.0M
Q3 25
$-10.0M
$-1.2M
Q2 25
$-15.4M
$-3.3M
Q1 25
$-20.3M
$-3.7M
Q4 24
$-817.8K
Q3 24
$-1.8M
Q2 24
$-225.5K
FCF Margin
BBNX
BBNX
LPTH
LPTH
Q1 26
Q4 25
-32.8%
12.0%
Q3 25
-36.7%
-8.1%
Q2 25
-66.2%
-27.3%
Q1 25
-115.1%
-40.0%
Q4 24
-11.0%
Q3 24
-21.2%
Q2 24
-2.6%
Capex Intensity
BBNX
BBNX
LPTH
LPTH
Q1 26
Q4 25
5.9%
5.3%
Q3 25
4.7%
0.5%
Q2 25
7.7%
5.6%
Q1 25
1.9%
4.6%
Q4 24
1.1%
Q3 24
0.9%
Q2 24
3.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BBNX
BBNX

Segment breakdown not available.

LPTH
LPTH

Other$7.9M48%
Infrared Components$5.0M31%
Visible Components$3.4M21%

Related Comparisons